CN107789583A - 一种消除骨转移癌细胞的药物组合物及其制备方法 - Google Patents
一种消除骨转移癌细胞的药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN107789583A CN107789583A CN201711372573.7A CN201711372573A CN107789583A CN 107789583 A CN107789583 A CN 107789583A CN 201711372573 A CN201711372573 A CN 201711372573A CN 107789583 A CN107789583 A CN 107789583A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- metastatic carcinoma
- bone cell
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 36
- 208000011645 metastatic carcinoma Diseases 0.000 title claims abstract description 31
- 206010061289 metastatic neoplasm Diseases 0.000 title claims abstract description 31
- 210000002449 bone cell Anatomy 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 239000003814 drug Substances 0.000 claims abstract description 69
- 239000000203 mixture Substances 0.000 claims abstract description 22
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 20
- 244000050510 Cunninghamia lanceolata Species 0.000 claims abstract description 14
- 241000779819 Syncarpia glomulifera Species 0.000 claims abstract description 12
- 239000001739 pinus spp. Substances 0.000 claims abstract description 12
- 229940036248 turpentine Drugs 0.000 claims abstract description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 11
- 235000008434 ginseng Nutrition 0.000 claims abstract description 11
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 9
- 241000132012 Atractylodes Species 0.000 claims abstract description 9
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 9
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 9
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 9
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 9
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 9
- 239000009636 Huang Qi Substances 0.000 claims abstract description 9
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 9
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 9
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 9
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 9
- 235000005412 red sage Nutrition 0.000 claims abstract description 9
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 8
- 244000164480 Curcuma aromatica Species 0.000 claims abstract description 8
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims abstract description 8
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims abstract description 8
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 8
- 235000019509 white turmeric Nutrition 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims description 18
- 210000003734 kidney Anatomy 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 230000001737 promoting effect Effects 0.000 claims description 6
- 230000017531 blood circulation Effects 0.000 claims description 5
- 235000014347 soups Nutrition 0.000 claims description 5
- 239000007938 effervescent tablet Substances 0.000 claims description 4
- 241000411851 herbal medicine Species 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 210000002784 stomach Anatomy 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 210000000952 spleen Anatomy 0.000 claims description 2
- 230000008030 elimination Effects 0.000 claims 5
- 238000003379 elimination reaction Methods 0.000 claims 5
- 235000013605 boiled eggs Nutrition 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000002398 materia medica Substances 0.000 claims 1
- 235000015277 pork Nutrition 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 30
- 230000000694 effects Effects 0.000 abstract description 15
- 208000002193 Pain Diseases 0.000 abstract description 13
- 230000036407 pain Effects 0.000 abstract description 13
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 238000000605 extraction Methods 0.000 abstract description 3
- 238000001727 in vivo Methods 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 208000020084 Bone disease Diseases 0.000 abstract 1
- 230000007717 exclusion Effects 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 42
- 201000011510 cancer Diseases 0.000 description 41
- 210000004027 cell Anatomy 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 206010005949 Bone cancer Diseases 0.000 description 11
- 238000007654 immersion Methods 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 10
- 239000002574 poison Substances 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 230000000711 cancerogenic effect Effects 0.000 description 7
- 231100000315 carcinogenic Toxicity 0.000 description 7
- 238000002512 chemotherapy Methods 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 6
- 201000007270 liver cancer Diseases 0.000 description 6
- 208000014018 liver neoplasm Diseases 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 208000001780 epistaxis Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000035939 shock Effects 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 206010003445 Ascites Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000002386 leaching Methods 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000002751 lymph Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- PPKXEPBICJTCRU-XMZRARIVSA-N (R,R)-tramadol hydrochloride Chemical compound Cl.COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 PPKXEPBICJTCRU-XMZRARIVSA-N 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 241000218691 Cupressaceae Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 2
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 2
- 206010053159 Organ failure Diseases 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010061926 Purulence Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010041519 Spider naevus Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000010352 nasal breathing Effects 0.000 description 2
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 231100000155 toxicity by organ Toxicity 0.000 description 2
- 230000007675 toxicity by organ Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 229960003107 tramadol hydrochloride Drugs 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000024188 Andala Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- LHFKHAVGGJJQFF-UEOYEZOQSA-N Hydroxy-alpha-sanshool Chemical compound C\C=C\C=C\C=C/CC\C=C\C(=O)NCC(C)(C)O LHFKHAVGGJJQFF-UEOYEZOQSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- DINOPBPYOCMGGD-VEDJBHDQSA-N Man(a1-2)Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)O3)O)O2)O)[C@@H](CO)O1 DINOPBPYOCMGGD-VEDJBHDQSA-N 0.000 description 1
- 206010027452 Metastases to bone Diseases 0.000 description 1
- 206010058117 Ocular icterus Diseases 0.000 description 1
- 241000218633 Pinidae Species 0.000 description 1
- 235000005205 Pinus Nutrition 0.000 description 1
- 241000218602 Pinus <genus> Species 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 235000021168 barbecue Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000001815 biotherapy Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001612 cachectic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 238000004939 coking Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000007232 portal hypertension Diseases 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 210000001154 skull base Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及一种消除骨转移癌细胞的药物组合物及其制备方法,由玄参、杉木(屑)、松节、人参、灵芝、川芎、当归、白术、熟地、黄芪、红花、桃仁、丹参、赤芍、三棱、莪术、三七等组成,取其药物组合物水煎、清蒸提取制备的药剂,可消除骨转移癌细胞,尤其是用于清除体内“垃圾”,药物直达病灶能把骨转移癌细胞排除体外,达到消除骨转移癌细胞的目的,无明显毒副作用。克服了目前治疗骨转移癌症药物治标不治本、镇痛不彻底、有毒副作用的缺点。
Description
技术领域
本发明涉及一种消除骨转移癌细胞的药物组合物及其制备方法。
背景技术
癌症是危害人类健康最严重的疾病之一,被称为绝症。放疗最大的缺陷是在病灶形成焦块,留下了复发的祸根。且易造成正常组织的损伤,限制了给予肿瘤组织较大的剂量,对有潜在远位转移的病例无能为力。化疗正邪俱损,有全身毒副作用。介入疗法虽然是化疗的进步,正邪俱损的比例有了很大程度的调整,可以说是局部化疗,虽然不伤害全身,但对局部脏腑器官的损害更大,很容易导致器官中毒衰竭。手术治疗的最大缺陷有二:一是切割癌瘤时,也破坏了人体的有机整体平衡;二是切割癌瘤手术不干净不彻底,会留下飞速扩散转移 葫芦起来瓢”的后果。基因疗法的最大缺陷是费用相当昂贵。生物疗法对免疫抗拒性肿瘤治疗无效。目前的中药治疗克服了以上大部分缺陷,注重整体观念,辨证施治。然而,以毒攻毒存在着毒副作用,小剂量的中药疗效慢、疗期长且效果不稳定。至今未见一种消除骨转移癌细胞的人道主义绿色疗法药物组合物及其制备方法用于治疗癌症。
早期癌症几乎没有什么症状,对人体的危害也不大,很难被发现,一旦出现症状时,往往已到了癌症的中晚期,特别是中晚期癌症患者癌细胞骨转移的治疗,不仅花钱多而且难度大,特别是对身体的伤害是极为残忍的: 骨转移很快会导致骨折,骨转移很快会导致患者失去造血功能,这样,消除骨转移癌细胞就显得极为重要了。目前被动抗癌的药物不少,至今未见一种消除骨转移癌细胞的药物组合物及其制备方法的人道主义绿色疗法的药物组合物。
玄参为玄参科多年生草本植物玄参的根,别名元参、黑参。性味功能:甘、苦、咸、微寒、入肺、胃、肾经。滋阴降火、清热解毒、散结消痈、治热病烦渴、发斑、骨蒸劳热、夜寐不宁、自汗盗汗、津伤便秘、吐血衄血、咽喉肿痛、痈肿、瘰疬。用法用量:内服:煎汤3—5钱,或入丸、散。外用:捣敷或研末调敷。
杉木屑(杉木)为杉科植物的心材和树枝及锯木屑。性味功能:辛、微温,下气降逆,消胀止痛,祛湿消肿。用法用量:内服:煎汤,1—2两。
松节为少常用中药。始载《名医别录》。
别名:油松节。
来源:松柏科植物常绿乔木油松马尾松的含油节疤。
产地 :全国有松树处皆有产。
性状鉴别:多为圆片状或不规则的块状。两端有刀痕或锯痕,显年轮,黄棕色或红棕色,体重质坚,易燃。燃烧时冒黑烟,并有油渗出。有松节油气,味微辣。以色红油性足者为佳。
主要成分:含树脂、挥发油。
功效与作用:祛风燥湿。其作用可能为镇痛。
炮制:切片生用。
性味:苦温。
归经:入肝、肾经。
功能:祛风燥湿,活血止痛。
主治:风湿性关节疼痛或外伤肿痛。多用于洗药,内服者较少。
临床应用:适用于筋骨、关节风湿痹痛,配入复方或单用浸酒服,方如风湿二方。
与桑枝比较,两者都能祛风湿,但松节祛风湿偏于寒者,桑枝祛风湿偏于热者,各有所长。
用量:9~15g。
以上植物药具有开发资源丰富、来源方便、成本较低、易于推广的优点。
发明内容
本发明的目的是提供一种消除骨转移癌细胞的药物组合物及其制备方法,克服了目前被动抗癌和手术、放化疗、介入疗法及目前中草药治癌的不足。
本发明的目的是通过以下技术方案来实现的:一种消除骨转移癌细胞的药物组合物及其制备方法,主要是由内服药物组合物的治疗方法来完成。
本发明一种消除骨转移癌细胞的药物组合物及其制备方法,内服药物组合物由玄参、杉木(屑)、松节、人参、灵芝、川芎、当归、白术、熟地、黄芪、红花、桃仁、丹参、赤芍、三棱、莪术、三七等组成。所述药物组合物的制备方法包括以下步骤:水煎提取或按药剂常用方法制备。所述制备方法,还包括药物组合物提取物浓缩或浸膏后,按常规制备口服药的方法制备而成的口服药,其中水煎剂可直接服用或制成口服液。所述药剂是指任何一种药剂学上所说的口服给药剂型,尤其是指颗粒剂、胶囊剂、片剂(含泡腾片)和口服液。
所述一种消除骨转移癌细胞的药物组合物为主要有以下原料重量份组合制备而成的制剂:玄参1—800份、杉木(屑)1—500份、松节1—500份、人参1—100份、灵芝1—100份、川芎1—500份、当归1—500份、白术1—500份、熟地1—500份、黄芪1—500份、红花1—200份、桃仁1—500份、丹参1—500份、赤芍1—500份、三棱1—500份、莪术1—500份、三七1—500份。
优选为:玄参10—600份、杉木(屑)10—300份、松节10—200份、人参5—20份、灵芝5—50份、川芎10—100份、当归10—100份、白术10—100份、熟地10—100份、黄芪10—100份、红花10—50份、桃仁10—100份、丹参10—100份、赤芍10—100份、三棱10—100份、莪术10—100份、三七10—100份。
最优选为:玄参300份、杉木(屑)50份、松节50份、人参5份、灵芝10份、川芎20份、当归20份、白术50份、熟地50份、黄芪50份、红花10份、桃仁20份、丹参20份、赤芍20份、三棱20份、莪术20份、三七20份。
本发明一种消除骨转移癌细胞的药物组合物,其制备方法包括以下步骤:水煎提取或按药剂常用方法制备,所述制备方法,还包括药物组合物提取物浓缩或浸膏后,按常规制备口服药的方法制备而成的口服药,其中水煎剂可直接服用或制成口服液。取所述组分水煎后每天饭后两服或三服,所述制备方法还可以加入药学上可用的辅料,所述药剂是指任何一种药剂学上所说的口服给药剂型,尤其是指颗粒剂、胶囊剂、片剂、泡腾片和口服液,最佳为汤剂,汤者荡也。
本发明药物组合物组方的药理为:所述组分君药为玄参,滋阴降火、软坚散结、软化血管、滋阴生津凉血、清热解毒,扶正又祛邪,且祛邪不伤正;臣药为人参、灵芝、川芎、当归、白术、熟地、黄芪,气血双补又升阳,脾肺肾通补,能提高免疫能力;红花、桃仁、丹参、赤芍、三棱、莪术、三七,活血化瘀为佐药;杉木(屑)、松节为使药,通经活络,引药通关。
本发明一种消除骨转移癌细胞的药物组合物及其制备方法的具体实施操作过程:取所述组分先用冷水浸泡30分钟,用水量为水没过药,然后水煎两次混合,第一次水煎时间为沸腾后45分钟,倒出第一次水煎药液后,再加水没过药。第二次水煎时间为沸腾后30分钟,把两次水煎提取药液混合浓缩为400毫升,或按药剂常用方法制备。
一种消除骨转移癌细胞的药物组合物及其制备方法主要是由内服药物组合物的治疗方法,内服药物组合物处方水煎剂或其他口服给药剂型:颗粒剂、胶囊剂、片剂(含泡腾片)和口服液。
本发明有以下的效果和优点:
1、本发明提供的药物组合物,取其水煎、清蒸提取制备的药剂,可消除骨转移癌细胞,尤其是用于清除体内“垃圾”,排除体内癌毒。本发明注重强化生命动力,强化有机体能源,调整生命有机整体平衡,滋养先天肾水肾气,保健后天脾胃,充分调动人体有机体本身的祛邪力量,一方面配合人体机能工作,一方面直达病灶攻坚;一方面釜底抽薪,优化康复环境,一方面使癌细胞休克。玄参、昆布(海带、海藻)能清火解毒、软坚散结,清火软坚直达病灶,釜底抽薪,使癌细胞休克,恶化癌细胞的生存环境,加上活血化瘀、解毒散结的药物直达病灶,把休克的癌细胞排除体外。
2、克服了目前被动抗癌的不足,克服了目前治疗癌症的手术疗法破坏有机整体和易导致远位转移的缺点,克服了放化疗、介入疗法及中草药以毒攻毒的毒副作用缺点。
3、疗效特好,无明显毒副作用。
四、临床病例报告
用药物组合物煎剂直接口服治疗患者21例,初步结果小结如下:
1、一般资料
1.1病例选择
21例中,淋巴癌骨转移4例、肝癌骨转移5例、乳腺癌骨转移4例、胃癌骨转移3例、肺癌骨转移5例。
1.2性别及年龄:
男9例,女12例, 40—50岁3例,50—60岁12例,60—70岁6例。
1.3恶性肿瘤情况
①最大的恶性肿瘤患者谢××,男性,42岁,湖南永兴县的村民,肝癌肿块除多个结节外最大肿块为165mm×148mm×132mm,病灶疼痛难忍,有蜘蛛痣,明显消瘦,伴有贫血,皮肤、巩膜黄染,大便紧,已腹水。服两剂药后,大便拉出白色脓团,服十剂药后,精神状况恢复如健康人,脸色红润,腹水消失。服药三个月,骨转移的癌细胞消失,肝癌肿块由165mm×148mm×132mm,缩小为142mm×132mm×112mm。
②最典型的患者是常XX,淋巴癌患者,女,五十六岁,湖南长沙人,癌细胞已经入肺入骨髓,经过化疗后气息微弱,几乎一天二十四小时难能入睡,一旦打瞌睡就会浑身痒得难受而且盗汗。喝了一剂药后一共拉了十一次,还精神多了!一个月后,骨髓里的癌细胞没有了,三个月后,所有的淋巴肿瘤全部消失。
③年龄最大的患者为曹××,男性,63岁,湖南永兴县的村民,查为鼻咽癌侵犯颅底、斜坡,蝶骨大翼骨质破坏,头痛、衄血相当严重。颈上淋巴瘤多个、两鼻孔已堵塞,口干喉燥,心烦且躁,用药前靠盐酸曲马多镇痛,医院通知准备后事。服药一剂一服不到一小时疼痛消除,服药十剂后,从两鼻孔出来条状腐肉,双鼻呼吸通畅,服药期间,未出现鼻衄,淋巴瘤缩小,服药二十剂后,骨转移的癌细胞消失。
2、治疗方法:
首先服药物组合物一天一剂两服或三服。
3、治疗结果:
3.1、服药物组合物水煎剂,直到完全消除肿块。所有患者服药后无明显副作用,有效率99、3%。
4、讨论:
癌症是由于气、血、痰、食受阻导致的火毒内蕴。癌症病的形成,主要是以下几方面:一是饭菜中的农药残留物在体内集聚毒素致癌;二是煎炸烧烤、烘炒食品、酸性食品助火致癌;三是腐烂馊臭变质食品、坛子菜、焦化食品含致癌物;四是食品添加剂含致癌物;五是先天遗传和后天病史所致的弱势器官容易病变恶化致癌;六是先天性的性格内向、孤僻、不开朗豁达易导致气、血、痰、食受阻致癌;七是生活节奏快、生活工作压力大、烦恼多,影响心理素质、性格修养、思维方式、观念意识、价值目标,导致气、血、痰、食受阻致癌;八是空气和水质污染致癌;九是内服的西药和外用的日化产品致癌;十是工业污染和工作环境致癌。
本发明一种消除骨转移癌细胞的药物组合物及其制备方法,主要是注重强化生命动力,强化生命机体能源,调整生命有机体整体平衡,滋养先天肾水肾气,保健后天脾胃。一方面配合人体机能工作,一方面活血化瘀直达病灶攻坚;一方面釜底抽薪,优化康复环境;一方面使癌细胞休克。张元素说过,“玄参乃枢机之剂,管领诸气上下,肃清而不浊”。《纲目》:“肾水受伤,真阳失守,孤阳无根,发为火病,法宜壮水以制火,故玄参与地黄同功。其消瘰疬亦是散火,刘守真言结核是火病。”《药品化义》:“肾之脏虚则热而燥,宜凉补之,独此凉润滋肾胜知、柏,特为肾脏君药。”《本草正义》:“玄参禀至阴之性,专主热病,味苦则泄降下行,故能治脏腑热结等症。味又辛而微咸,故直造血分而通血瘀,亦能外行于经隧,而消散结热之痈肿。寒而不峻,润而不腻------较为和缓,流弊差轻。”《医学衷中参西录》:“至滋阴清胃汤中重用亦必以四物汤中归芍辅之,此所谓小心放胆并行不悖也。”
癌症是因为气、血、痰、食受阻而导致的火毒内蕴。玄参能凉血生津、滋阴生精养肾、泄热制火、解毒排毒,不仅能治癌防癌,而且能让人类特别是男人青春常在,是为君药。玄参能够凉血生津、泄热制火和中和病灶癌细胞赖以生存且活跃的酸性环境,使癌细胞的生存环境碱性化,也就是恶化了癌细胞的生存环境,有利于正常健康细胞生存发展。酸助火、癌细胞嗜酸,一旦生存环境碱性化,癌细胞便昏迷休克了。
玄参是寒凉药物,量小不起作用,量大患者承受不了,这样,杉木(屑)和松节就可以起作用了。首先是温寒药性的中和作用,还有就是下逆气、散湿毒,具有燥湿开发升窜功能。《本草经疏》:“取其芬芳解漆气之秽恶,辛温能散湿毒之冲逆也。”《日华子》:“治霍乱上气,无非假其下气散邪,辛温开发之功耳。”《本草汇言》:“味辛温,直达开发升窜之性。”“此药气味芬芳,能下逆气,散毒邪,有开达内出之功,大能发扬火郁,疏申肝令,独擅其长者矣。” 加上活血化瘀药物的加入,能消除骨转移癌细胞。
5、结论
本发明药物组合物能消除骨转移癌细胞的药物组合物同时强身健体,有效率99、3%,且疗效好,疗程短,无明显副作用,是相当理想的消除骨转移癌细胞的首选药物。然而,本发明对治疗化疗和介入疗法后的器官中毒、身体相当虚弱患者及器官衰竭、消化功能衰竭者无效。
6、注意事项
体质偏好的患者可照说明书的说明正常服药物组合物,服药期间一定要腹泻排毒,腹泻不伤身体。所述药物组合物中的杉木(屑)是指杉木心材、树枝及其锯杉木的屑任选一种入药。
7、禁忌
本发明一种消除骨转移癌细胞的药物组合物及其制备方法,对化疗和介入疗法导致的恶病质患者及器官衰竭、消化功能衰竭者禁用,对脾胃相当虚寒,服药前大便溏且泄的患者禁用,对胃门静脉高压和癌栓患者禁用。
典型病例1
常XX,淋巴癌患者,女,五十六岁,湖南长沙人,癌细胞已经入肺入骨髓,经过化疗后气息微弱,几乎一天二十四小时难能入睡,一旦打瞌睡就会浑身痒得难受而且盗汗。喝了一剂药后一共拉了十一次,还精神多了!一个月后,骨髓里的癌细胞没有了,三个月后,所有的淋巴肿瘤全部消失。
典型病例2
曹××,男性,43岁,湖南永兴县居民,查为胃癌骨转移,检查前胃痛较以前加重且出现骨头部位疼痛,靠盐酸曲马多镇痛,服药一个半月后,骨髓里的癌细胞没有了。
典型病例3
曹××,男性,63岁,湖南永兴县的村民,查为鼻咽癌侵犯颅底、斜坡,蝶骨大翼骨质破坏,头痛、衄血相当严重。颈上淋巴瘤多个、两鼻孔已堵塞,口干喉燥,心烦且躁,用药前靠盐酸曲马多镇痛,医院通知准备后事。服药一剂一服不到一小时疼痛消除,服药十剂后,从两鼻孔出来条状腐肉,双鼻呼吸通畅,服药期间,未出现鼻衄,淋巴瘤缩小,服药二十剂后,骨转移的癌细胞消失。
典型病例4
刘XX,女,五十三岁,湖南永兴县村民,患有肺癌骨转移,检查前已经疼痛,经过两个多月的治疗,骨髓里的癌细胞没有了。
典型病例5
谢××,男性,42岁,湖南永兴县的村民,肝癌骨转移,肝癌肿块除多个结节外最大肿块为165mm×148mm×132mm,病灶和胸骨疼痛难忍,有蜘蛛痣,明显消瘦,伴有贫血,皮肤、巩膜黄染,大便紧,已腹水。服两剂药后,大便拉出白色脓团,服十剂药后,精神状况恢复如健康人,脸色红润,腹水消失。服药三个月,骨转移的癌细胞消失,肝癌肿块由165mm×148mm×132mm,缩小为142mm×132mm×112mm。
具体实施方式
实施例1
本发明药物组合物(1)煎剂
取药物组合物(1)加常量水煎后收集浸液,再加水重复一次煎,浸液混合装瓶,患者每天饭后分三次或两次服完。
实施例2
本发明药物组合物(1)口服液
取药物组合物(1)加常量的水煎后收集浸液,再加水重复一次煎,浸液混合浓缩,按常规制成口服液装瓶,患者每天饭后分三次或两次服完。
实施例3
本发明药物组合物(1)胶囊剂
取药物组合物(1)加常量的水煎后收集浸液,再加水重复一次煎,浸液混合浓缩成浸膏,制粒20目,装胶囊,制成胶囊剂,患者每天饭后分三次或两次服完。
实施例4
本发明药物组合物(1)片剂
取药物组合物(1)加常量的水煎后收集浸液,再加水重复一次煎,浸液混合浓缩成浸膏,整粒20目,压片制成片剂,患者每天饭后分两次或三次服完。
实施例5
本发明药物组合物(1)颗粒剂
取药物组合物(1)加常量的水煎后收集浸液,再加水重复一次煎,浸液混合浓缩成浸膏,整粒20目,成颗粒剂,病人每天饭后分二次或三次服完。
Claims (7)
1.一种消除骨转移癌细胞的药物组合物,主要是由玄参、杉木(屑)、松节、人参、灵芝、川芎、当归、白术、熟地、黄芪、红花、桃仁、丹参、赤芍、三棱、莪术、三七或药学上可用辅料制备而成的制剂。
2.根据权利要求1的一种消除骨转移癌细胞的药物组合物,所述药物为以下重量份原料组分:主要是有以下重量份原料制备成的制剂:玄参1—800份、杉木(屑)1—500份、松节1—500份、人参1—100份、灵芝1—100份、川芎1—500份、当归1—500份、白术1—500份、熟地1—500份、黄芪1—500份、红花1—200份、桃仁1—500份、丹参1—500份、赤芍1—500份、三棱1—500份、莪术1—500份、三七1—500份。
3.根据权利要求1、2的一种消除骨转移癌细胞的药物组合物及其制备方法,所述药物组合物的药物为中药市场经炮制或野生及种植的药物。
4.根据权利1、2、3的一种消除骨转移癌细胞的药物组合物、其组合物兑清蒸猪瘦肉汤和煎剂煮鸡蛋的制备方法,包括以下步骤:取药物组合物水煎两次后混合,每天两服或三服。
5.根据权利要求1、2、3、4的一种消除骨转移癌细胞的药物组合物,取药物组合物水煎,再按药剂常用方法制备,在玄参药物组合物基础上,还可以兑加其它温补的滋补品及处方中草药,所述药物是指任何一种药剂学上所说的口服给剂型:口服液、颗粒剂、胶囊剂、片剂、泡腾片等。
6.根据权利要求1、2、3、4、5的一种消除骨转移癌细胞的药物组合物,所述原料组分为以下重量份组分:玄参300份、杉木(屑)50份、松节50份、人参5份、灵芝10份、川芎20份、当归20份、白术50份、熟地50份、黄芪50份、红花10份、桃仁20份、丹参20份、赤芍20份、三棱20份、莪术20份、三七20份。
7.根据权利要求1、2、3、4、5、6的一种消除骨转移癌细胞的药物组合物,所述原料组分可以是辩证施治,由药物组合物和其它活血补血,补中益气,补肾健脾胃,软坚化瘀等强化生命动力,强化生命机体能源,调整生命有机整体平衡的处方中草药组成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711372573.7A CN107789583A (zh) | 2017-12-19 | 2017-12-19 | 一种消除骨转移癌细胞的药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711372573.7A CN107789583A (zh) | 2017-12-19 | 2017-12-19 | 一种消除骨转移癌细胞的药物组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107789583A true CN107789583A (zh) | 2018-03-13 |
Family
ID=61537988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711372573.7A Pending CN107789583A (zh) | 2017-12-19 | 2017-12-19 | 一种消除骨转移癌细胞的药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107789583A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107137517A (zh) * | 2017-07-03 | 2017-09-08 | 曹国荣 | 消除癌痛治疗癌症的植物药和药物组合物及其制备方法 |
-
2017
- 2017-12-19 CN CN201711372573.7A patent/CN107789583A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107137517A (zh) * | 2017-07-03 | 2017-09-08 | 曹国荣 | 消除癌痛治疗癌症的植物药和药物组合物及其制备方法 |
Non-Patent Citations (1)
Title |
---|
姚桂安: ""抗癌散"治疗恶性肿瘤116例临床小结", 《实用中医内科杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104436009B (zh) | 肝癌药 | |
CN103301356B (zh) | 一种慢性肾衰竭用灌肠液制备方法 | |
CN107137517A (zh) | 消除癌痛治疗癌症的植物药和药物组合物及其制备方法 | |
CN104758762A (zh) | 一种治疗肺痨的中药组合物 | |
CN108057107A (zh) | 一种快速缩小和消除恶性肿瘤的药物组合物及其制备方法 | |
CN103301355A (zh) | 一种慢性肾衰竭结肠透析液制备方法 | |
CN103285343B (zh) | 一种治疗肝癌的药物及其制备方法 | |
CN103798472B (zh) | 一种保健茶及保健养生制剂 | |
CN111643557B (zh) | 一种防治下肢深静脉血栓后遗症期的药物组合物及其制备方法和用途 | |
CN107184869A (zh) | 一种治疗痛风降尿酸的药物组合物及其制备方法 | |
CN102908425A (zh) | 一种治疗心脏病及血脂稠的药物及其制备方法 | |
CN107789583A (zh) | 一种消除骨转移癌细胞的药物组合物及其制备方法 | |
CN102335370A (zh) | 一种加味逐瘀通脉药物组合物及其制备方法 | |
CN107184936A (zh) | 治疗脑癌的药物组合物及其制备方法 | |
CN105106710A (zh) | 医治哮喘的润肺化痰制剂的制备方法 | |
CN107823343A (zh) | 一种治疗风湿关节炎的药物组合物和药酒及其制备方法 | |
CN107982351A (zh) | 一种消除癌症患者浑身奇痒的药物组合物及其制备方法 | |
CN106822369A (zh) | 一种止泻中药及其制备方法 | |
CN105920139A (zh) | 一种抗癌防癌中药茶 | |
CN104547695B (zh) | 一种用于治疗三叉神经痛的药物组合物及其应用 | |
CN107362232A (zh) | 治疗血癌的植物药和药物组合物及其制备方法 | |
CN109700974A (zh) | 一种镇痛、抗肿瘤的吴茱萸复方精油及其制备方法 | |
CN104758673A (zh) | 一种治疗中风后遗症的中药组合物 | |
CN105106651A (zh) | 一种治疗清气不升型神经性耳聋的中药及制备方法 | |
CN104645061A (zh) | 一种治疗瘀血停滞型慢性胃溃疡的药物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180313 |